It Will Take More Than US Bargaining Power to Cut Drug Costs
Summary
“The drug industry has historically been successful with these Chicken Little arguments,” says Michelle Mello, a professor of health policy at Stanford Law School. “But I think people will see this come online and notice that the sky hasn’t fallen and they kind of like not being gouged on high-cost drugs.”
Read More